Coronary heart disease and estrogen plus progestin treatment

the "burden" of the evidence

Authors

  • Álvaro Nagib Atallah SPMJ

Downloads

Download data is not yet available.

References

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280(7):605-13.

Eccles M, Freemantle N, Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. Br Med J 1998;316(7139):1232-5.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350(9084):1047-59.

Downloads

Published

1999-03-03

How to Cite

1.
Atallah Álvaro N. Coronary heart disease and estrogen plus progestin treatment: the "burden" of the evidence. Sao Paulo Med J [Internet]. 1999 Mar. 3 [cited 2026 May 6];117(2):47-8. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2443

Issue

Vol. 117 No. 2 (1999)

Section

Editorial

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.